| 000 | 03327nam a2200445 i 4500 | ||
|---|---|---|---|
| 001 | 0000178877 | ||
| 005 | 20171002064324.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 100607t20112011pauad ob 001 0 eng|d | ||
| 020 | _z9781605474311 (hardback : alk. paper) | ||
| 035 | _a(CaPaEBR)ebr10824498 | ||
| 040 |
_aCaPaEBR _beng _erda _epn _cCaPaEBR |
||
| 050 | 1 | 4 |
_aRC271.C5 _bC32219 2011eb |
| 082 | 0 | 4 |
_a616.99/4061 _222 |
| 245 | 0 | 0 |
_aCancer chemotherapy and biotherapy : _bprinciples and practice / _cBruce A. Chabner, Dan L. Longo. |
| 250 | _aFifth edition. | ||
| 264 | 1 |
_aPhiladelphia : _bWolters Kluwer Health/Lippincott Williams & Wilkins, _c[2011] |
|
| 264 | 4 | _c©2011 | |
| 300 |
_a1 online resource (836 pages) : _billustrations (some color) |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _asection I. Basic principles of cancer treatment -- section II. Cytotoxic agents -- section III. Molecularly targeted therapies -- section IV. Immunologic agents -- section V. Hormonal therapy -- section VI. Supportive care -- section VII. Survivorship. | |
| 520 | _a"Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents--their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Chapters emphasize pharmacology and mechanisms of action at the molecular and cellular levels, followed by clinical activity and toxicity, both acute and delayed. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. The previous edition was one of "Doody's Core Titles 2009." This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised"--Provided by publisher. | ||
| 588 | _aDescription based on print version record. | ||
| 590 | _aElectronic reproduction. Palo Alto, Calif. : ebrary, 2014. Available via World Wide Web. Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 |
_aCancer _xChemotherapy. |
|
| 650 | 0 |
_aCancer _xImmunotherapy. |
|
| 650 | 0 | _aAntineoplastic agents. | |
| 650 | 0 | _aBiological response modifiers. | |
| 655 | 0 | _aElectronic books. | |
| 700 | 1 | _aChabner, Bruce. | |
| 700 | 1 |
_aLongo, Dan L. _q(Dan Louis), _d1949- |
|
| 776 | 0 | 8 |
_iPrint version: _tCancer chemotherapy and biotherapy : principles and practice. _dPhiladelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, [2011] _hxv, 812 pages, 4 unnumbered pages of plates ; 29 cm _z9781605474311 _w(DNLM)101532629 _w(DLC)10824498 |
| 797 | 2 | _aebrary. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/daystar/Doc?id=10824498 _zAn electronic book accessible through the World Wide Web; click to view |
| 908 | _a170314 | ||
| 942 | 0 | 0 | _cEB |
| 999 |
_c168015 _d168015 |
||